CD274 and osteosarcoma: This research is expected to provide additional knowledge regarding the mechanisms of PD-L1 regulation in osteosarcoma, in the hope of becoming a catalyst for further research on this topic and the basis for anti-PD-L1 combination therapy with other targets involved in PD-L1 regulation, with the end goal of yielding better outcomes for the patients.